Stock Market News

Merck stock rises on successful Phase 3 trial results for its cholesterol drug

Jun 9, 2025 - 12:10
 0
Merck stock rises on successful Phase 3 trial results for its cholesterol drug
Read More

Tags:

Previous Article

Samsara Is Thriving, But Just Getting Started (Upgrade)

Next Article

TSX futures edge higher as traders eye key U.S.-China trade talks

Related Posts

United to ramp up luxury services amid robust demand for premium travel

United to ramp up luxury services amid robust demand fo...

May 13, 2025  0

Belgium stocks lower at close of trade; BEL 20 down 0.38%

Belgium stocks lower at close of trade; BEL 20 down 0.38%

Jun 11, 2025  0

Bernstein downgrades CrowdStrike on valuation, sees bet...

Jun 6, 2025  0